NCT00613067View on ClinicalTrials.gov

ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

April 30, 2010

Study Completion Date

May 31, 2010

Conditions
Generalized Anxiety Disorder
Interventions
DRUG

escitalopram

"* Start with escitalopram 10mg~* According to patient's symptoms, stay on 10mg or increase up to 20mg~* Concomitant therapy : up to Xanax 0.5mg, or Ativan 1mg, not allowed above these dosages~* Length of washout period will be at least 2 weeks for any psychotropic drugs"

Trial Locations (1)

414-410

Psychiatry department, Inje Univ. Ilsanpaik Hospital, Goyang

All Listed Sponsors
lead

Inje University

OTHER

NCT00613067 - ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder | Biotech Hunter | Biotech Hunter